Rationalizing lead optimization by associating quantitative relevance with molecular structure modification.
Historically, one of the characteristic activities of the medicinal chemist has been the iterative improvement of lead compounds until a suitable therapeutic entity is achieved. Often referred to as lead optimization, this process typically takes the form of minor structural modifications to an existing lead in an attempt to ameliorate deleterious attributes while simultaneously trying to maintain or improve desirable properties. The cumulative effect of this exercise performed over the course of several decades of pharmaceutical research by thousands of trained researchers has resulted in large collections of pharmaceutically relevant chemical structures. As far as the authors are aware, this work represents the first attempt to use that data to define a framework to quantifiably catalogue and summate this information into a medicinal chemistry expert system. A method is proposed that first comprehensively mines a compendium of chemical structures compiling the structural modifications, abridges them to rectify artificially inflated support levels, and then performs an association rule mining experiment to ascribe relative confidences to each transformation. The result is a catalogue of statistically relevant structural modifications that can potentially be used in a number of pharmaceutical applications.
Raymond
John W
JW
Discovery Informatics and Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA. raymond_john_w@lilly.com
Watson
Ian A
IA
Mahoui
Abdelaziz
A
D002626:Chemistry, Pharmaceutical; D015195:Drug Design; D005103:Expert Systems; D051188:Knowledge Bases; D007854:Lead; D013329:Structure-Activity Relationship
D007854:Lead